Developing a pipeline for training psychedelic therapy facilitators is one of the most challenging issues to face in the coming years, as it is necessary to tackle the controversiality surrounding it to prevent black-market charlatans, which pose their problems. A certification program is being developed that can be applied to psychiatric MD training for people who want to add this type of training and qualification to their existing track, which is likely to bring MDMA-assisted therapy down the pipeline first since it is the most advanced in treating PTSD.